| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |